We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Next Generation of Rapid Diagnostic Assays Will Combine Disposable Test Materials with Smartphone Applications

By LabMedica International staff writers
Posted on 26 Apr 2015
Print article
Image: Thin, lightweight, and flexible materials integrate cellulose paper and flexible polyester films as new diagnostic tools to detect biological agents in whole blood, serum, and peritoneal fluid (Photo courtesy of Florida Atlantic University).
Image: Thin, lightweight, and flexible materials integrate cellulose paper and flexible polyester films as new diagnostic tools to detect biological agents in whole blood, serum, and peritoneal fluid (Photo courtesy of Florida Atlantic University).
The new generation of rapid diagnostic tests will reflect advances in both materials sciences and instant communications via the Internet and social media.

Current diagnostic assays commonly require long assay time, sophisticated infrastructure, and expensive reagents that are not compatible with resource-constrained and geographically isolated settings. While paper and flexible material-based platform technologies provide alternative approaches for the development of point-of-care (POC) diagnostic assays for broad applications in medicine, they lack the capability of transferring test results to a central location.

Investigators at Florida Atlantic University (Boca Raton, USA), Stanford University (Palo Alto, CA, USA), and Harvard University (Cambridge, MA, USA) have been working to integrate cellulose paper and flexible polyester film-based assays with dedicated smartphone applications.

In a recently published paper, the investigators presented a snapshot of the current state of the art. They described the use of three different paper and flexible material-based platforms with embedded electrical and optical sensing modalities to develop tests for the selective and accurate capture and detection of multiple biological targets. Finger prick volume equivalents of biological specimens such as whole blood, plasma, and peritoneal dialysis effluent were tested. Viruses (Human immunodeficieny virus 1), bacteria (Escherichia coli and Staphylococcus aureus), and cells (CD4+ T lymphocytes) were identified with clinically relevant levels of detection and sensitivity. A smartphone application was developed that allowed images of the test results to be sent from a cellular telephone for analysis anywhere in the world.

"The future of diagnostics and health monitoring will have potentially cell-phone based or portable readers sipping saliva or blood and continuously monitoring human health taking it way beyond where we are with counting steps today," said senior author Dr. Uktan Demirci, associate professor of radiology at Stanford University.

The paper was published in the March 6, 2015, online edition of the journal Nature Scientific Reports.

Related Links:

Florida Atlantic University
Stanford University
Harvard University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.